Vanda Pharmaceuticals Inc.
$321.69M- Market cap
- $328.31M
- Debt
- +$78.23M
- Cash
- −$84.85M
Capital structure 81% equity / 19% debt · EV / Revenue 1.49x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
VNDA · current priceP/S 1.52x
$5.43Latest market snapshot
Implied fair value · at GATX's multiple
$12.91137.8% above market
3.57 VNDA revenue / share×3.61x GATX P/S=$12.91
Market $5.43Implied $12.91
GATX · current priceP/S 3.61x
$178.11Latest market snapshot
Implied fair value · at VNDA's multiple
$74.8958.0% below market
49.30 GATX revenue / share×1.52x VNDA P/S=$74.89
Market $178.11Implied $74.89